Quaternized Cationic Carbon Dots as Antigen Delivery Systems for Improving Humoral and Cellular Immune Responses
Shaomei Huang,Bowen Li,Usama Ashraf,Qi Li,Xingchang Lu,Xiaochen Gao,Min Cui,Muhammad Imran,Jing Ye,Feifei Cao,Jiangjiang Gu,Shengbo Cao
DOI: https://doi.org/10.1021/acsanm.0c02062
IF: 6.14
2020-08-05
ACS Applied Nano Materials
Abstract:Adjuvant selection in vaccines is a key to induce potent immune responses. The current licensed adjuvant alum is found to be insufficient to induce cellular immune responses and a balanced Th1/Th2 ratio, which are desirable against cancers and microbial infections. Hence, it is encouraged to develop adjuvants which can simultaneously improve cell-mediated and humoral immune responses of the antigen and possess a favorable Th1/Th2 balance. Herein, quaternized cationic carbon dots derived from biquaternary ammonium salt (BQAS-CDs) were newly prepared, and their adjuvanticity and biocompatibility were preliminarily explored in vivo. The developed BQAS-CDs are enriched in quaternary ammonium groups on the surface, which enable them to bind to and aggregate with the negatively charged ovalbumin (OVA). The resulting BQAS-CDs + OVA nanocomplexes dramatically enhance the uptake of antigen by the antigen-presenting cells (APCs). Compared to the conventional adjuvant alum, the BQAS-CDs + OVA nanocomplexes significantly increase the anti-OVA IgG2a and IgG2b levels and keep the level of the OVA-specific IgG1 antibody, inducing both robust Th1- and Th2-type immune responses. Furthermore, they stimulate the proliferation of OVA-specific CD4<sup>+</sup> and CD8<sup>+</sup> T cells. No significant alterations were observed in the hematological and histological parameters of BQAS-CDs + OVA-immunized recipients. These findings suggest the potential benefits of BQAS-CDs as an alternative adjuvant in the future.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsanm.0c02062?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsanm.0c02062</a>.EA results of BQAS and BQAS-CDs; QY calculations of BQAS-CDs; <sup>1</sup>H NMR spectrum of BQAS; AFM results of BQAS-CDs; DLS results of BQAS-CDs; XRD patterns of BQAS-CDs; XPS spectra of BQAS-CDs and BQAS; PL spectra of BQAS-CDs at different pHs; effect of pH, ion strength, temperature, and UV irradiation time on BQAS-CDs; cytotoxicity test and cellular imaging results of BQAS-CDs; photograph of BQAS-CDs, OVA, and BQAS-CDs + OVA solutions; SEM images of OVA and BQAS-CDs + OVA; storage time effect on the size of BQAS-CDs + OVA; circular dichroism spectra of BQAS-CDs, OVA, and BQAS-CDs + OVA; UV–vis results of BQAS-CDs, OVA, and the upper solution of the BQAS-CDs + OVA complex after centrifugation; confocal fluorescence images of RAW264.7 cells cultured with BQAS-CDs + OVA-FITC or OVA-FITC; cellular uptake of BQAS-CDs + OVA at 4 °C; effect of BQAS-CDs on the body weight of vaccinated mice; and blood count analysis of mice with PBS- or OVA-based materials (<a class="ext-link" href="/doi/suppl/10.1021/acsanm.0c02062/suppl_file/an0c02062_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.
materials science, multidisciplinary,nanoscience & nanotechnology